Clinical Report: Sugar-Sweetened Beverages May Raise Risk of Hepatic Cancer Subtypes
Overview
Higher consumption of sugar-sweetened beverages is associated with an increased risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Background
Hepatic cancer, particularly hepatocellular carcinoma (HCC), is a significant public health concern. This study investigates the relationship between sugar-sweetened and artificially-sweetened beverage intake and hepatic cancer risk.
Data Highlights
| Type of Beverage | Increased Risk of HCC | Increased Risk of ICC |
|---|---|---|
| Sugar-Sweetened Beverages | 10% per additional beverage | 15% per additional beverage |
| Artificially-Sweetened Beverages | No association | No association |
Key Findings
- Each additional daily sugar-sweetened beverage is associated with a 10% higher likelihood of HCC.
- Each additional daily sugar-sweetened beverage is associated with a 15% higher likelihood of ICC.
- Artificially-sweetened beverage intake is not associated with overall hepatic cancer risk.
- Subgroup analyses show consistent findings among participants with and without diabetes.
- Self-reported beverage consumption limits the assessment of changes over time.
- Most participants were from predominantly White populations, affecting generalizability.
Clinical Implications
Healthcare professionals should consider dietary intake of sugar-sweetened beverages when assessing liver cancer risk in patients. Further research may be needed to explore the long-term effects of beverage consumption on hepatic health.
Conclusion
The study reports a link between sugar-sweetened beverage consumption and specific hepatic cancer subtypes.
Related Resources & Content
- JAMA Network Open, 2023 -- Sugar-Sweetened and Artificially Sweetened Beverages and Liver Cancer—A Hard Look at Soft Drinks
- The ASCO Post, 2016 -- Increased Risk of Gallbladder Cancer May Be Associated With Consuming Large Amounts of Sweetened Beverages
- JAMA Network Open, 2023 -- Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer
- The ASCO Post, 2023 -- Does Daily Consumption of Sugar-Sweetened Beverages Increase the Risk of Liver Disease Among Postmenopausal Women?
- EASL, 2024 -- New EASL Clinical Practice Guidelines on Hepatocellular Carcinoma
- PMC, 2023 -- Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision
- Nature Food, 2025 -- Proteomic signatures of sweetened beverages are associated with higher risk of adverse liver outcomes
- New EASL Clinical Practice Guidelines on Hepatocellular Carcinoma - EASL-The Home of Hepatology.
- Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision - PMC
- Proteomic signatures of sweetened beverages are associated with higher risk of adverse liver outcomes | Nature Food
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
